Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Oxlantic Medical AB
AB
Active
Org 5594211418
Ulls Väg 29 C, 756 51
Uppsala
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2023
5 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Oxlantic Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
-2M
2024
-22M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
0
0
60
Staff expenses
−166
−1 267
−6 565
EBITDA
−233
−2 045
−21 588
Depreciation & amort.
—
—
−291
EBIT
−233
−2 045
−21 880
Net financials
0
1
292
Profit before tax
—
—
—
Tax
—
—
—
Net profit
−232
−2 044
−21 589
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
10 077
8 433
21 153
Equity
9 213
7 168
18 432
Long-term debt
—
—
—
Short-term debt
865
1 264
2 721
Total debt
865
1 264
2 721
Financial ratios
5-year trend
EBITDA margin
-36013.0%
This company
15.8%
Market median
-228030% vs market
2023
2025
Equity ratio
87.1%
This company
38.2%
Market median
+128% vs market
2023
2025
Return on equity
-117.1%
This company
18.4%
Market median
-736% vs market
2023
2025
Net profit margin
-36013.9%
This company
8.1%
Market median
-444716% vs market
2023
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-02-07 – 2023-12-31
View
PDF
More on Oxlantic Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
